[HTML] frontiersin.org

[HTML][HTML] Intermediate-vs. standard-dose prophylactic anticoagulation in patients with COVID-19 admitted in medical ward: a propensity score-matched cohort study

DM Smadja, G Bonnet, N Gendron, O Weizman… - Frontiers in …, 2021 - frontiersin.org
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …
被引用次数：15 相关文章
[PDF] scienceopen.com

[PDF][PDF] Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron, O Weizman… - scienceopen.com
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …

Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study.

DM Smadja, G Bonnet, N Gendron, O Weizman… - Frontiers in …, 2021 - europepmc.org
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …
[HTML] nih.gov

[HTML][HTML] Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …

Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron… - Frontiers in …, 2021 - hal.sorbonne-universite.fr
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …

Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron, O Weizman… - Frontiers in …, 2021 - hal.science
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …

Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …
[PDF] sorbonne-universite.fr

[PDF][PDF] Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

DM Smadja, G Bonnet, N Gendron, O Weizman… - hal.sorbonne-universite.fr
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …

Intermediate-vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study.

DM Smadja, G Bonnet, N Gendron, O Weizman… - Frontiers in …, 2021 - europepmc.org
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …